Yifeng Pharmacy - Asset Resilience Ratio

Latest as of September 2025: 19.16%

Yifeng Pharmacy (603939) has an Asset Resilience Ratio of 19.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Yifeng Pharmacy to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥4.99 Billion
≈ $730.88 Million USD Cash + Short-term Investments

Total Assets

CN¥26.07 Billion
≈ $3.82 Billion USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Yifeng Pharmacy's Asset Resilience Ratio has changed over time. See Yifeng Pharmacy (603939) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Yifeng Pharmacy's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603939 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥4.99 Billion 19.16%
Total Liquid Assets CN¥4.99 Billion 19.16%

Asset Resilience Insights

  • Good Liquidity Position: Yifeng Pharmacy maintains a healthy 19.16% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Yifeng Pharmacy Industry Peers by Asset Resilience Ratio

Compare Yifeng Pharmacy's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Redcare Pharmacy NV
F:RDC
Pharmaceutical Retailers 9.15%
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
Pharmaceutical Retailers 0.01%
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.38%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.00%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 2.05%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.03%
Dashenlin Pharm Grp Co Ltd
SHG:603233
Pharmaceutical Retailers 0.80%
Laobaixing Pharmacy
SHG:603883
Pharmaceutical Retailers 0.01%

Annual Asset Resilience Ratio for Yifeng Pharmacy (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Yifeng Pharmacy.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 15.75% CN¥4.41 Billion
≈ $644.85 Million
CN¥27.97 Billion
≈ $4.09 Billion
+9.00pp
2023-12-31 6.76% CN¥1.63 Billion
≈ $238.63 Million
CN¥24.14 Billion
≈ $3.53 Billion
+6.52pp
2022-12-31 0.24% CN¥50.05 Million
≈ $7.32 Million
CN¥21.04 Billion
≈ $3.08 Billion
-0.65pp
2021-12-31 0.89% CN¥152.19 Million
≈ $22.27 Million
CN¥17.05 Billion
≈ $2.50 Billion
-4.86pp
2020-12-31 5.75% CN¥744.84 Million
≈ $108.99 Million
CN¥12.95 Billion
≈ $1.89 Billion
+3.65pp
2019-12-31 2.11% CN¥193.23 Million
≈ $28.28 Million
CN¥9.18 Billion
≈ $1.34 Billion
-1.61pp
2018-12-31 3.72% CN¥292.76 Million
≈ $42.84 Million
CN¥7.87 Billion
≈ $1.15 Billion
-15.89pp
2017-12-31 19.61% CN¥937.87 Million
≈ $137.24 Million
CN¥4.78 Billion
≈ $699.84 Million
-15.49pp
2016-12-31 35.10% CN¥1.48 Billion
≈ $216.80 Million
CN¥4.22 Billion
≈ $617.70 Million
+24.55pp
2015-12-31 10.55% CN¥257.00 Million
≈ $37.61 Million
CN¥2.44 Billion
≈ $356.56 Million
--
pp = percentage points

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers
Market Cap
$3.53 Billion
CN¥24.13 Billion CNY
Market Cap Rank
#4538 Global
#782 in China
Share Price
CN¥19.90
Change (1 day)
+0.61%
52-Week Range
CN¥19.70 - CN¥26.22
All Time High
CN¥967.78
About

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to… Read more